Cargando…
Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM
Background: Evolving targeted therapy on Janus Associated Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signaling pathway, especially pertaining to STAT-3 protein in non-Hodgkin lymphoma (NHL), provides new treatment strategies. STAT-3 protein also relates to the prognostication...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178068/ https://www.ncbi.nlm.nih.gov/pubmed/37175040 http://dx.doi.org/10.3390/diagnostics13091649 |
_version_ | 1785040772184145920 |
---|---|
author | Muhamad, Izyan Rifhana Che Ibrahim, Noorul Balqis Hussain, Faezahtul Arbaeyah |
author_facet | Muhamad, Izyan Rifhana Che Ibrahim, Noorul Balqis Hussain, Faezahtul Arbaeyah |
author_sort | Muhamad, Izyan Rifhana |
collection | PubMed |
description | Background: Evolving targeted therapy on Janus Associated Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signaling pathway, especially pertaining to STAT-3 protein in non-Hodgkin lymphoma (NHL), provides new treatment strategies. STAT-3 protein also relates to the prognostication of NHL. Hence, we aimed to evaluate the expression of STAT-3 protein in NHL cases diagnosed in Hospital Universiti Sains Malaysia (USM). Methods: A retrospective cross sectional study using formalin fixed paraffin embedded (FFPE) tissue blocks of 95 NHL cases were obtained. STAT-3 immunostaining was performed and evaluated. The proportion and association between the expression of STAT-3 protein with subtypes of NHL were statistically analyzed. Results: The majority of the cases (78.9%) had positive STAT-3 protein expression. 64.2% were among aggressive B cell NHL, whilst 20.0% of them were diffuse large B cell lymphoma, a non-germinal center B subtype (DLBCL-NGCB). There is also an association between STAT-3 protein expression with DLBCL subtypes (p = 0.046). Conclusion: Our study demonstrated a remarkable expression of STAT-3 protein in NHL, in which DLBCL subtypes had significant association. A larger scale study with a combination of JAK protein evaluation should be undertaken in the future. |
format | Online Article Text |
id | pubmed-10178068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101780682023-05-13 Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM Muhamad, Izyan Rifhana Che Ibrahim, Noorul Balqis Hussain, Faezahtul Arbaeyah Diagnostics (Basel) Article Background: Evolving targeted therapy on Janus Associated Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) signaling pathway, especially pertaining to STAT-3 protein in non-Hodgkin lymphoma (NHL), provides new treatment strategies. STAT-3 protein also relates to the prognostication of NHL. Hence, we aimed to evaluate the expression of STAT-3 protein in NHL cases diagnosed in Hospital Universiti Sains Malaysia (USM). Methods: A retrospective cross sectional study using formalin fixed paraffin embedded (FFPE) tissue blocks of 95 NHL cases were obtained. STAT-3 immunostaining was performed and evaluated. The proportion and association between the expression of STAT-3 protein with subtypes of NHL were statistically analyzed. Results: The majority of the cases (78.9%) had positive STAT-3 protein expression. 64.2% were among aggressive B cell NHL, whilst 20.0% of them were diffuse large B cell lymphoma, a non-germinal center B subtype (DLBCL-NGCB). There is also an association between STAT-3 protein expression with DLBCL subtypes (p = 0.046). Conclusion: Our study demonstrated a remarkable expression of STAT-3 protein in NHL, in which DLBCL subtypes had significant association. A larger scale study with a combination of JAK protein evaluation should be undertaken in the future. MDPI 2023-05-07 /pmc/articles/PMC10178068/ /pubmed/37175040 http://dx.doi.org/10.3390/diagnostics13091649 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Muhamad, Izyan Rifhana Che Ibrahim, Noorul Balqis Hussain, Faezahtul Arbaeyah Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM |
title | Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM |
title_full | Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM |
title_fullStr | Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM |
title_full_unstemmed | Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM |
title_short | Evaluation of Signal Transducer and Activator of Transcription 3 (STAT-3) Protein Expression in Non-Hodgkin Lymphoma Cases in Hospital USM |
title_sort | evaluation of signal transducer and activator of transcription 3 (stat-3) protein expression in non-hodgkin lymphoma cases in hospital usm |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178068/ https://www.ncbi.nlm.nih.gov/pubmed/37175040 http://dx.doi.org/10.3390/diagnostics13091649 |
work_keys_str_mv | AT muhamadizyanrifhana evaluationofsignaltransducerandactivatoroftranscription3stat3proteinexpressioninnonhodgkinlymphomacasesinhospitalusm AT cheibrahimnoorulbalqis evaluationofsignaltransducerandactivatoroftranscription3stat3proteinexpressioninnonhodgkinlymphomacasesinhospitalusm AT hussainfaezahtularbaeyah evaluationofsignaltransducerandactivatoroftranscription3stat3proteinexpressioninnonhodgkinlymphomacasesinhospitalusm |